Yutaka Niihara, Chairman and CEO, 10% Owner at Emmaus Life Sciences, Inc. (EMMA), bought 52,600 shares at $0.38 ($21K) on 2022-11-29, disclosed to the SEC on 2022-12-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.45 | 2,500 | $1K | 5.3% |
| 2 | $0.45 | 7,500 | $3K | 15.9% |
| 3 | $0.35 | 5,000 | $2K | 8.2% |
| 4 | $0.38 | 14,700 | $6K | 26.3% |
| 5 | $0.41 | 22,900 | $9K | 44.2% |
| Total | $0.40 avg | 52,600 |
| $21K |
| 100% |
| Filing → |
| EMMA | BUY | 2022-10-24 | $11K | — | Filing → |
| EMMA | BUY | 2022-10-19 | $9K | — | Filing → |
| EMMA | BUY | 2022-10-17 | $17K | — | Filing → |